Form 4: Cullinan Therapeutics' Chief Medical Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Jeffrey Alan Jones, Chief Medical Officer of Cullinan Therapeutics, sold 4,895 shares of common stock on February 25, 2025, to cover personal income tax obligations.
Summary
- On February 25, 2025, Jeffrey Alan Jones, the Chief Medical Officer of Cullinan Therapeutics, Inc. (CGEM), sold 4,895 shares of common stock.
- The sale was executed at a price of $8.53 per share.
- This transaction reduced Jones' direct holdings to 174,164 shares of common stock.
- The sale was conducted to cover personal income tax obligations arising from the vesting of restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral event. An executive selling shares to cover tax obligations is a common practice and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions, allowing investors to see if those with inside knowledge of the company are buying or selling shares. It is a routine transaction to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/25/2025 | Date of the stock sale transaction. |
| 02/27/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.